Order results by:
| Issue | Title | |
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Microbiota markers level in the cerebrospinal fluid of patients with multiple sclerosis and radiologically isolated syndrome | Abstract similar documents |
| A. N. Boyko, M. V. Melnikov, O. V. Boyko, A. R. Kabaeva, M. A. Omarova, O. G. Zhilenkova, A. M. Zatevalov, V. S. Rogovskii | ||
| "... on microbiota markers in the cerebrospinal fluid (CSF) of patients with MS and predisposing conditions ..." | ||
| Vol 16, No 6 (2024) | Evaluation of the content of microbial metabolites in cerebrospinal fluid of individuals with radiologically isolated syndrome | Abstract similar documents |
| M. A. Omarova, O. G. Zhilenkova, A. N. Boyko | ||
| "... found a statistically significant increase in the content of microbiota markers in the CSF ..." | ||
| Vol 14, No 2 (2022) | New potential biomarkers of Alzheimer's disease: markers of endothelial dysfunction and neuroinflammation. | Abstract similar documents |
| A. K. Minochkin, V. Yu. Lobzin, N. N. Suchentseva, O. S. Popov, S. V. Apalko, S. G. Sherbak | ||
| "... is a marker of endothelial dysfunction, may be an indicator of the severity of the vascular neurodegenerative ..." | ||
| Vol 16, No 3 (2024) | Biological markers of Alzheimer's disease in cerebrospinal fluid: clinical and laboratory comparisons | Abstract similar documents |
| K. V. Shevtsova, D. O. Rozhkov, D. A. Grishina, V. V. Grinyuk, V. V. Zakharov, N. M. Kashakanova, N. N. Koberskaya, O. V. Kosivtsova, A. B. Lokshina, Yu. A. Starchina, A. Yu. Tyurina, A. Yu. Fedorova, V. A. Parfenov | ||
| "... , detection of biological markers (biomarkers) of AD in the cerebrospinal fluid (CSF) is of great importance ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Free circulating miRNA as a potential diagnostic marker in multiple sclerosis (review) | Abstract similar documents |
| M. A. Omarova, M. S. Kozin, A. N. Boyko | ||
| "... of the expression of protein coding genes, are known to be present in CSF and can be considered as potential markers ..." | ||
| Vol 17, No 1 (2025) | Subjective and functional cognitive impairment: diagnostics using biological markers of Alzheimer's disease | Abstract PDF (Eng) similar documents |
| V. A. Parfenov, D. A. Grishina, A. B. Lokshina, V. V. Zakharov, K. V. Shevtsova, Ya. I. Chervyakova | ||
| "... ) at the SCI stage using biological markers for AD in cerebrospinal fluid (CSF). The article presents ..." | ||
| Vol 5, No 4 (2013) | Value of determining the cerebrospinal fluid protein markers of amyloidosis and neurodegeneration in the diagnosis of vascular and neurodegenerative cognitive impairments | Abstract similar documents |
| Vladimir Yuryevich Lobzin, A Yu Emelin, M M Odinak, L A Alekseeva, N E Monakhova | ||
| "... их трансформации в деменцию. Выполнено исследование цереброспинальной жидкости (ЦСЖ) у 60 пациентов с ..." | ||
| Vol 17, No 3 (2025) | Mild cognitive impairment due to cerebrovascular disease and Alzheimer’s | Abstract similar documents |
| V. A. Parfenov, D. A. Grishina, A. B. Lokshina, V. V. Grinyuk, V. V. Zakharov, K. V. Shevtsova | ||
| "... as the cause of MCI, biological markers in the cerebrospinal fluid (CSF) can be used, such as low Aβ42 levels ..." | ||
| Vol 15, No 4 (2023) | The role of trimethylamine-N-oxide in the development of cerebrovascular disease (brief review) | Abstract similar documents |
| M. A. Kutlubaev, A. R. Rakhmatullin, R. F. Kutlubaeva | ||
| "... Trimethylamine-N-oxide (TMO) is one of the best studied metabolites of the gut microbiota ..." | ||
| Vol 14, No 1 (2022) | Impact of endothelial inflammation on depression in patients with cerebral microangiopathy: a prospective study | Abstract similar documents |
| O. V. Vorobyeva, A. A. Pilipovich, V. V. Fateeva | ||
| "... between the level of peripheral markers of endothelial inflammation and depression severity in patients ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Genome-wide polygenic analysis of multiple sclerosis markers | Abstract similar documents |
| Ya. R. Timasheva, T. R. Nasibullin, I. A. Tuktarova, V. V. Erdman, T. R. Galiullin, O. V. Zaplakhova, K. Z. Bakhtiiarova | ||
| "... Objective: to perform a genome-wide polygenic analysis of multiple sclerosis (MS) markers ..." | ||
| Vol 13, No 6 (2021) | Changes in retinal structures as markers of multiple sclerosis progression | Abstract similar documents |
| M. O. Poplyak, A. G. Trufanov, A. V. Temniy, D. S. Maltsev, O. B. Chakchir, A. V. Mikheev, D. I. Skulyabin, G. N. Bisaga, I. V. Litvinenko, M. M. Odinak | ||
| Vol 15, No 2 (2023) | Readiness potential as a neurophysiological marker of functional movement disorders | Abstract PDF (Eng) similar documents |
| V. A. Tolmacheva, E. N. Dudnik, R. M. Shishorin, D. S. Petelin, V. E. Bezrukov, A. N. Gamirova, Yu. V. Dolgopolova, B. A. Volel | ||
| "... research on searching for biological markers using methods such as functional magnetic resonance imaging ..." | ||
| Vol 16 (2024): (Suppl. 2) | Combined analysis of free kappa chains and central vein sign increases the specificity of multiple sclerosis diagnosis | Abstract similar documents |
| Sh. R. Nabiev, S. A. Dzhukkaeva, M. Sh. Asvedov, D. E. Prokhorov, E. V. Popova, V. V. Grinyuk, P. R. Magomadova, A. R. Apevalova, O. N. Voskresenskaya | ||
| "... parameters for the diagnosis of MS. This paves the way for the further inclusion of these two markers ..." | ||
| Vol 14, No 5 (2022) | Depression and polymorphism G-174C (rs1800795) of the IL-6 gene in an open population of 25–44 year old in Russia/Siberia (WHO international program MONICA-psychosocial) | Abstract similar documents |
| V. V. Gafarov, E. A. Gromova, D. O. Panov, V. N. Maksimov, I. N. Gagulin, A. V. Gafarova | ||
| Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders | Multidisciplinary clinical and biological characteristics of hyperkinetic disorders in childhood autism | Abstract similar documents |
| N. V. Simashkova, T. P. Klyushnik, L. P. Yakupova, A. A. Koval-Zaitsev, M. V. Lobacheva | ||
| "... psychosis) has pathopsychological markers as cognitive disontogenesis with delays in fine motor activity ..." | ||
| Vol 15, No 1 (2023) | The gut microbiome as a factor in the development of Parkinson's disease | Abstract similar documents |
| L. A. Brsikyan, E. A. Poluektova, M. G. Poluektov | ||
| "... , and then spread to the brain. Changes in the intestinal microbiota composition can contribute to the development ..." | ||
| Vol 8, No 3 (2016) | EEG markers of cognitive impairments in patients with coronary artery disease | Abstract similar documents |
| I. V. Tarasova, I. N. Kukhareva, O. L. Barbarash | ||
| Vol 16, No 2 (2024) | Diagnosis of Alzheimer's disease by using biological markers in posterior cortical atrophy | Abstract similar documents |
| D. A. Grishina, N. A. Khayalieva, V. V. Grinyuk, A. Yu. Tyurina | ||
| "... The use of biological markers for Alzheimer's disease (AD) allows diagnosis at the stage ..." | ||
| Vol 17, No 2 (2025) | Differences in cerebrospinal fluid microRNA profiles in patients with remitting multiple sclerosis and patients with other neurological diseases | Abstract similar documents |
| М. А. Omarova, М. S. Kozin, А. N. Boyko | ||
| "... as a diagnostic marker for MS needs to be confirmed in independent samples. ..." | ||
| Vol 13, No 2 (2021) | Association of polymorphic marker Val158Met of COMT gene with depression in an open population 25–44 years old (WHO international program MONICA, epidemiological study) | Abstract PDF (Eng) similar documents |
| V. V. Gafarov, E. A. Gromova, D. O. Panov, V. N. Maksimov, I. V. Gagulin, A. V. Gafarova | ||
| "... Objective: to investigate the association of the polymorphic marker Val158Met in the catechol-O ..." | ||
| Vol 17, No 3 (2025) | Cognitive impairment in patients with chronic cerebral ischemia (discirculatory encephalopathy) | Abstract similar documents |
| V. A. Parfenov, E. V. Silina | ||
| "... , with definitive diagnosis relying on detection of biological markers of the disease. Unfortunately, many patients ..." | ||
| Vol 11, No 3 (2019) | Early cognitive dysfunction as a marker for the poor course of multiple sclerosis: a prospective 12-year follow-up | Abstract similar documents |
| D. S. Kasatkin, S. S. Molchanova, N. N. Spirin | ||
| Vol 16, No 2 (2024) | Alzheimer's disease: diagnosis and treatment, errors in patient management | Abstract similar documents |
| V. A. Parfenov, D. A. Grishina, A. Yu. Tyurina | ||
| "... on clinical findings and is confirmed by the presence of positive biological markers of the disease, which ..." | ||
| Vol 14, No 2 (2022) | Association between redox imbalance, pterin metabolism markers, and early extrapyramidal side effects of antipsychotics in schizophrenia: pilot study | Abstract similar documents |
| T. V. Zhilyaeva, D. S. Shvachkina, A. S. Piatoikina, E. S. Zhukova, O. V. Kostina, T. G. Shcherbatyuk, G. E. Mazo | ||
| Vol 10, No 1 (2018) | A relationship between the integrated assessment of magnetic resonance imaging markers for cerebral small vessel disease and the clinical and functional status in the acute period of ischemic stroke | Abstract PDF (Eng) similar documents |
| A. A. Kulesh, N. A. Kaileva, N. Kh. Gorst, V. V. Shestakov | ||
| "... . There is no generally accepted magnetic resonance imaging (MRI) scale for the integrated assessment of CSVD markers ..." | ||
| Vol 10, No 4 (2018) | The brain’sglymphatic system:physiological anatomy and clinical perspectives | Abstract similar documents |
| V. N. Nikolenko, M. V. Oganesyan, N. N. Yakhno, E. A. Orlov, E. E. Porubayeva, E. Yu. Popova | ||
| "... жидкости и растворимых соединений из ЦНС в цереброспинальную жидкость (ЦСЖ), что компенсирует отсутствие ..." | ||
| Vol 16, No 3 (2024) | Concentration of immunoglobulin free light chains in cerebrospinal fluid in the diagnosis of multiple sclerosis | Abstract PDF (Eng) similar documents |
| Sh. R. Nabiev, S. A. Dzhukkaeva, M. Sh. Asvedov, D. E. Prokhorov, E. V. Popova, V. V. Grinyuk, P. R. Magomadova, A. R. Apevalova, O. N. Voskresenskaya | ||
| "... свободных легких цепей иммуноглобулинов в цереброспинальной жидкости (ЦСЖ) для диагностики и ..." | ||
| Vol 3, No 4 (2011) | New criteria for diagnosing Alzheimer's disease | Abstract similar documents |
| A. Yu. Emelin | ||
| "... for the early diagnosis of AD, including its preclinical diagnosis using the laboratory and neuroimaging markers ..." | ||
| Vol 13, No 5 (2021) | Biological basis of aggressive behavior | Abstract similar documents |
| O. A. Makushkina, O. I. Gurina, V. A. Golenkova | ||
| "... behavior and the urgency of determining biological markers of social danger. Finally, questions ..." | ||
| Vol 10, No 3 (2018) | Hemorrhagic manifestations of cerebral amyloid angiopathy: from pathogenesis to clinical significance | Abstract similar documents |
| A. A. Kulesh, V. E. Drobakha, V. V. Shestakov | ||
| "... pathogenesis. It presents in detail the current neuroimaging markers of CAA and their neuropathological ..." | ||
| Vol 11, No 1 (2019) | Cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus | Abstract similar documents |
| B. G. Adleyba, G. V. Gavrilov, A. V. Stanishevsky, B. V. Gaydar, D. V. Svistov, V. Yu. Lobzin, K. A. Kolmakova | ||
| "... возрастает роль биомаркеров цереброспинальной жидкости (ЦСЖ) в дифференциальной диагностике иНТГ и ..." | ||
| Vol 17, No 3 (2025) | Structure of the subarachnoid lymphatic-like membrane as a meningeal selective barrier and immunological regulator | Abstract similar documents |
| V. N. Nikolenko, M. V. Oganesyan, K. I. Urazmetova, N. A. Rizaeva, M. V. Sankova, А. V. Moiseeva, A. A. Moiseenko, A. A. Belichenko, A. T. Nikitina, L. A. Gridin | ||
| "... , выполняет функции управления иммунными клетками, регулирования тока цереброспинальной жидкости (ЦСЖ), защиты ..." | ||
| Vol 9, No 3 (2017) | Vascular cognitive impairment, no dementia: diagnosis, prognosis, treatment, and prevention | Abstract similar documents |
| A. A. Kulesh, V. V. Shestakov | ||
| "... , their epidemiology, risk markers and pathological basis. It describes in detail the neuropsychological ..." | ||
| Vol 6, No 4 (2014) | The epidemiological, clinical, and genetic characteristics of Parkinson’s disease (in case of Zheleznogorsk) | Abstract similar documents |
| M. R. Sapronova, N. A. Shnaider | ||
| "... consideration is being given to a search for genetic markers for the LRRK2 6055G>T mutation in exon 41, which ..." | ||
| Vol 10, No 4 (2018) | Sporadic cerebral non-amyloid microangiopathy: pathogenesis, diagnosis, and features of treatment policy | Abstract similar documents |
| A. A. Kulesh, V. E. Drobakha, V. V. Shestakov | ||
| "... presents the current neuroimaging markers of SCNAMA with a detailed discussion of lacunar infarcts ..." | ||
| Vol 12, No 4 (2020) | Current concept of the pathophysiology of migraine and new targets for its therapy | Abstract PDF (Eng) similar documents |
| G. R. Tabeeva, Z. Katsapava | ||
| "... that explain the leading clinical manifestations of migraine, as well as to identify some biological markers ..." | ||
| Vol 6, No 2S (2014): Special issue "Stroke" | Specific features of free radical processes in comorbid patients with acute stroke and transient ischemic attack | Abstract similar documents |
| A.S. Orlova, E.V. Silina, S.A. Rumyantseva, V.A. Stupin, N.I. Menshova, V.A. Orlov, T.G. Sinelnikova, S.B. Bolevich | ||
| "... . Plasma FRP was investigated over time from the oxygen and lipid peroxide markers of oxidative stress ..." | ||
| Vol 14, No 2 (2022) | Role of insular cortex lesions in determining the pathogenetic subtype of ischemic stroke | Abstract PDF (Eng) similar documents |
| A. A. Kulesh, S. P. Kulikova, V. E. Drobakha, S. A. Mekhryakov, E. V. Bartuli, A. V. Buzmakov, L. I. Syromyatnikova, K. V. Sobyanin, Yu. V. Karakulova | ||
| "... . Insular lesion is considered as a promising neuroimaging marker of CES. Objective: to analyze the role ..." | ||
| Vol 14, No 4 (2022) | The role of oxidative stress in the development of Alzheimer's disease | Abstract similar documents |
| V. N. Nikolenko, N. A. Rizaeva, K. V. Bulygin, V. M. Anokhina, A. A. Bolotskaya | ||
| "... be considered as markers of an early stage of AD. The main mechanisms of mitochondrial dysfunction, the damaging ..." | ||
| Vol 14, No 6 (2022) | Issues of improving the management of patients with ischemic stroke on the background of atrial fibrillation | Abstract similar documents |
| A. A. Kulesh, D. A. Demin | ||
| "... of atrial cardiopathy and its main markers. The principles for choosing the timing of oral anticoagulant ..." | ||
| Vol 12, No 3 (2020) | Oral anticoagulant therapy in patients after intracerebral hemorrhage | Abstract PDF (Eng) similar documents |
| A. A. Kulesh, L. I. Syromyatnikova | ||
| "... . The article discusses the vectors of recurrence for different types of IUD and their neuroimaging markers ..." | ||
| Vol 11, No 1 (2019) | The mechanisms for activation of a vascular platelet component of hemostasis in the stroke recovery period and the ways of their correction | Abstract similar documents |
| E. A. Tyutyumova, E. Yu. Solovyeva, A. N. Karneev, E. D. Dzhutova | ||
| "... the concentrations of the inflammatory marker myeloperoxidase and the endothelial dysfunction (ED) markers sICAM-1 ..." | ||
| Vol 16, No 5 (2024) | Resolution of the Expert Council on the problem of early diagnosis of Alzheimer's disease | Abstract similar documents |
| A. N. Bogolepova, E. E. Vasenina, N. V. Vakhnina, S. V. Vorobyеv, S. I. Gavrilova, А. Yu. Emelin, V. V. Zakharov, S. N. Illarioshkin, O. V. Kosivtsova, G. P. Kostyuk, O. S. Levin, E. A. Mkhitaryan, V. А. Parfenov, O. N. Tkacheva, Yu. A. Shpilyukova | ||
| "... of AD is possible when biological markers of the main pathological process (cerebral amyloidosis ..." | ||
| Vol 14, No 5 (2022) | Study of the role of carriage of single nucleotide variants of the IL-1β, TNFA, BDNF, NTRK-2 genes in the development and clinical features of temporal lobe epilepsy | Abstract PDF (Eng) similar documents |
| Yu. S. Panina, E. A. Domoratskaya, A. I. Paramonova, D. V. Dmitrenko | ||
| "... for the TE development markers, which make it possible to predict and evaluate the rate of disease ..." | ||
| Vol 15, No 2 (2023) | Depression in patients with cerebral microangiopathy | Abstract similar documents |
| A. N. Bogolepova | ||
| "... of lacunar infarcts, and other markers of vascular disease are shown. The available data suggest that various ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | The central vein sign in the differential diagnosis of multiple sclerosis | Abstract similar documents |
| S. E. Belov, A. N. Boyko | ||
| "... continues for specific markers of the disease, including those detected using neuroimaging techniques ..." | ||
| Vol 11, No 3 (2019) | Current views on neurosarcoidosis: pathogenesis, clinical manifestations, diagnosis | Abstract similar documents |
| M. S. Pushkaryov, L. M. Tibekina, L. P. Churilov | ||
| "... focus on searching for imaging, biological and/or immune markers that can reliably diagnose this disease ..." | ||
| Vol 10, No 1 (2018) | Vascular myelopathy: causes and mechanisms, possibilities of diagnosis and treatment | Abstract similar documents |
| G. V. Ponomarev, A. A. Skoromets, V. S. Krasnov, O. V. Rodionova, D. D. Glistenkova, N. F. Porkhun, S. A. Dambinova | ||
| "... stages. The investigation and introduction of specific biochemical markers (glutamate receptors ..." | ||
| Vol 7, No 1S (2015): Special issue "Epilepsy" | Risk factors for transition of febrile convulsions to epilepsy | Abstract similar documents |
| A. F. Dolinina, L. L. Gromova, K. Yu. Mukhin | ||
| "... EEG activity and abnormal structural neuroimaging are markers for the high probability of transition ..." | ||
| Vol 15, No 4 (2023) | Paramagnetic rim sign in multiple sclerosis | Abstract similar documents |
| D. V. Kapkanets, S. E. Belov, M. B. Dolgushin, A. N. Boyko | ||
| "... has high hopes for the discovery of new markers that will allow clarification of the diagnosis ..." | ||
| Vol 15, No 5 (2023) | The role of cellular immunity and systemic inflammation indices in the pathogenetic mechanisms of mental disorders | Abstract similar documents |
| A. P. Gorbunova, G. V. Rukavishnikov, E. D. Kasyanov, G. E. Mazo | ||
| "... markers that are difficult to replicate and not economically feasible for use in routine clinical practice ..." | ||
| Vol 10, No 1S (2018): СПЕЦВЫПУСК: ЭПИЛЕПСИЯ | The role of neuroinflammation in the pathogenesis of epilepsy | Abstract similar documents |
| L. V. Lipatova, N. B. Serebryanaya, N. A. Sivakova | ||
| "... здоровых доноров. Производилась оценка уровней цитокинов в плазме и цереброспинальной жидкости (ЦСЖ ..." | ||
| Vol 13, No 2 (2021) | Possibilities of using laboratory biomarkers for the objective diagnosis of depressive disorders | Abstract similar documents |
| V. K. Shamrey, E. S. Kurasov, Ya. S. Zobin, N. V. Tsygan | ||
| "... therapeutic approaches to treating RSDs. Conclusion. Usage of biological markers may contribute not only ..." | ||
| Vol 15, No 6 (2023) | Atrial cardiomyopathy in patients with cryptogenic embolic stroke: incidence, instrumental diagnostic features, impact on prognosis | Abstract PDF (Eng) similar documents |
| S. A. Chazov, S. A. Mekhryakov, A. A. Kulesh, L. I. Syromyatnikova, P. A. Astanin | ||
| "... foci and disease outcomes depending on the presence of the major markers for AC. Material and methods ..." | ||
| Vol 12, No 2 (2020) | Current approaches to diagnosing in intracerebral hemorrhage | Abstract PDF (Eng) similar documents |
| A. A. Kulesh | ||
| "... the ischemic and hemorrhagic markers of cerebral small vessel diseases. This examination is necessary not only ..." | ||
| Vol 12, No 4 (2020) | Depression and dementia: differentiation and comorbidity | Abstract similar documents |
| V. Yu. Lobzin, A. Yu. Emelin | ||
| "... for Alzheimer’s disease and to use the current lifetime markers for amyloidosis and neurodegeneration ..." | ||
| Vol 12, No 5 (2020) | The possibilities of diagnosing and treating cognitive impairment at non-dementia stages | Abstract similar documents |
| A. Yu. Emelin | ||
| "... and introduction of in vivo laboratory and neuroimaging markers of Alzheimer's, neurodegenerative, and vascular ..." | ||
| Vol 8, No 1 (2016) | SNAP-25 gene polymorphism and cognitive resource in patients with stroke sequels | Abstract similar documents |
| V. B. Vilyanov, G. N. Kobozev | ||
| "... . The polymorphism rs 363039 in the SNAP-25 gene may be used as a marker for predicting the cognitive resource ..." | ||
| Vol 12, No 4 (2020) | The main clinical and diagnostic characteristics of patients with low back pain and sacroiliac joint diseases (results of the IOLANTA-II study) | Abstract similar documents |
| I. A. Zolotovskaya, I. L. Davydkin | ||
| "... markers than those in Group 1, which suggests the relationship between pain syndrome and the presence ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Clinical presentation and course of multiple sclerosis in patients with herpesvirus infection | Abstract similar documents |
| M. S. Gris, N. S. Baranova, N. N. Spirin, D. S. Kasatkin, D. V. Kiselev, E. G. Shipova | ||
| "... – полимеразная цепная реакция из крови и цереброспинальной жидкости (ЦСЖ), олигоклональные IgG в сыворотке крови ..." | ||
| Vol 13, No 2 (2021) | Gender differences in the clinical course of depression in bipolar disorder | Abstract PDF (Eng) similar documents |
| N. A. Tyuvina, A. E. Stolyarova, D. V. Morozova, M. S. Verbitskaya | ||
| "... ). Therefore the most important clinical markers of BD in women include the early onset of the disease, its ..." | ||
| Vol 13, No 3 (2021) | Results of Expert Council meeting on modern principles of treatment optimization in patients with relapsing-remitting multiple sclerosis using anti-CD20 monoclonal antibody | Abstract similar documents |
| A. N. Boyko, N. V. Khachanova, D. S. Korobko, D. S. Kasatkin, Ya. V. Vlasov, E. P. Evdoshenko, E. V. Popova, K. Z. Bakhtiyarova, S. A. Sivertseva | ||
| "... potentials and optical coherence tomography, baseline vitamin D3 level as a prognostic marker of the disease ..." | ||
| Vol 14, No 3 (2022) | Neuropsychiatric disorders correction in Alzheimer's disease | Abstract similar documents |
| N. N. Koberskaya | ||
| "... . It is believed that the development of mental disorders (MD) is a marker of a number of additional adverse ..." | ||
| Vol 10, No 1 (2018) | Possible mechanisms of cognitive dysfunction in patients with chronic forms of cerebrovascular diseases | Abstract similar documents |
| O. N. Voskresenskaya, N. B. Zakharova, Yu. S. Tarasova, N. E. Tereshkina, V. A. Perepelov, E. M. Perepelova | ||
| "... with CI were found to have higher values of inflammatory markers, lower serum and plasma concentrations ..." | ||
| Vol 2, No 2 (2010) | Cervicogenic headache: the specific features of complex therapy with Amelotex and CompligamV | Abstract similar documents |
| M. L. Pospelova | ||
| "... dysfunction, a marker of activated blood coagulation; there was a rise in the content of antithrombin III ..." | ||
| Vol 12, No 6 (2020) | Biomarkers of atrial cardiopathy in patients with different pathogenetic subtypes of ischemic stroke | Abstract PDF (Eng) similar documents |
| S. A. Mekhryakov, A. A. Kulesh, L. I. Syromyatnikova, К. V. Sobyanin | ||
| "... , the diagnostic value of these markers and their threshold values require clarification. Objective: to present ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Polymorphic variants in the PVT1 locus affect multiple sclerosis severity | Abstract PDF (Eng) similar documents |
| I. S. Kiselev, M. S. Kozin, N. M. Baulina, G. V. Pavlova, A. N. Boyko, O. G. Kulakova, O. O. Favorova | ||
| "... for genomic markers that can predict the rate of disease progression at early stages. The impact ..." | ||
| Vol 8, No 4 (2016) | IMPACT OF ANTICOAGULANT THERAPY ON THE INDICATORS OF ARTERIAL STIFFNESS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ATRIAL FIBRILLATION AFTER CARDIOEMBOLIC STROKE | Abstract similar documents |
| I. A. Zolotovskaya, I. L. Davydkin, I. E. Poverennova, N. P. Romanchuk | ||
| "... lipoproteins, and triglycerides were determined. The markers of endothelial function, such as von Willebrand ..." | ||
| Vol 15 (2023): (Suppl. 1) | MicroRNAs as biomarkers of multiple sclerosis progression | Abstract similar documents |
| N. M. Baulina, I. S. Kiselev, O. G. Kulakova, E. V. Popova, O. O. Favorova, A. N. Boyko | ||
| "... to create a panel of prognostic markers for disease progression. Studies of miRNAs levels in both ..." | ||
| 1 - 70 of 81 Items | 1 2 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
